View in EDS

A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer.

Saved in:
Bibliographic Details
Title: A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer.
Authors: Rustin, G.1, Reed, N.2, Jayson, G. C.3, Ledermann, J. A.4, Adams, M.5, Perren, T.6, Poole, C.7, Lind, M.8, Persic, M.9, Essapen, S.10, Gore, M.11, Calvert, H.12, Stredder, C.13, Wagner, A.14, Giurescu, M.14, Kaye, S.11
Source: Annals of Oncology. Nov2011, Vol. 22 Issue 11, p2411-2416. 6p. 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdq780